共有 50 笔近期内部人交易记录记录，涉及 Inovio Pharmaceuticals, Inc. (INO), 包括 20 笔买入 和 30 笔卖出.
近期活跃的重要内部人包括 Sumner Michael John, Kies Peter, Humeau Laurent. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — INO
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-31 |
Sumner Michael John |
Chief Medical Officer |
期权行权（卖出） |
4,292 |
- |
- |
- |
| 2026-03-04 |
Kies Peter |
CFO |
限制性股票授予 (RSU) |
25,520 |
- |
- |
25,520 |
| 2026-03-04 |
Humeau Laurent |
Chief Scientific Officer |
限制性股票授予 (RSU) |
21,560 |
- |
- |
21,560 |
| 2026-03-04 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
限制性股票授予 (RSU) |
78,760 |
- |
- |
78,760 |
| 2026-03-04 |
Sumner Michael John |
Chief Medical Officer |
限制性股票授予 (RSU) |
29,608 |
- |
- |
29,608 |
| 2026-02-26 |
Kies Peter |
CFO |
期权行权（卖出） |
5,010 |
- |
- |
5,009 |
| 2026-02-26 |
Weiner David B. |
Director |
期权行权（卖出） |
972 |
- |
- |
- |
| 2026-02-26 |
Humeau Laurent |
Chief Scientific Officer |
期权行权（卖出） |
5,010 |
- |
- |
5,009 |
| 2026-02-26 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
期权行权（卖出） |
18,632 |
- |
- |
18,631 |
| 2026-02-26 |
Sumner Michael John |
Chief Medical Officer |
期权行权（卖出） |
5,010 |
- |
- |
5,009 |
| 2025-06-30 |
Sumner Michael John |
Chief Medical Officer |
期权行权（卖出） |
2,916 |
- |
- |
- |
| 2025-05-21 |
Yarno Wendy L |
Director |
期权行权（卖出） |
2,167 |
- |
- |
- |
| 2025-05-21 |
Benito Simon X |
Director |
期权行权（卖出） |
2,167 |
- |
- |
- |
| 2025-05-21 |
Zoth Lota S. |
Director |
期权行权（卖出） |
2,167 |
- |
- |
- |
| 2025-05-21 |
Shepard Jay |
Director |
期权行权（卖出） |
2,167 |
- |
- |
- |
| 2025-05-21 |
Weiner David B. |
Director |
期权行权（卖出） |
2,167 |
- |
- |
- |
| 2025-05-21 |
Dansey Roger D |
Director |
期权行权（卖出） |
2,167 |
- |
- |
- |
| 2025-05-21 |
Miller Ann Calby |
Director |
期权行权（卖出） |
2,167 |
- |
- |
- |
| 2025-05-20 |
Kies Peter |
CFO |
限制性股票授予 (RSU) |
26,100 |
- |
- |
26,100 |
| 2025-05-20 |
Humeau Laurent |
Chief Scientific Officer |
限制性股票授予 (RSU) |
18,081 |
- |
- |
18,081 |
| 2025-05-20 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
限制性股票授予 (RSU) |
84,888 |
- |
- |
84,888 |
| 2025-05-20 |
Sumner Michael John |
Chief Medical Officer |
限制性股票授予 (RSU) |
28,350 |
- |
- |
28,350 |
| 2025-05-15 |
Kies Peter |
CFO |
期权行权（卖出） |
4,771 |
- |
- |
4,771 |
| 2025-05-15 |
Humeau Laurent |
Chief Scientific Officer |
期权行权（卖出） |
4,771 |
- |
- |
4,771 |
| 2025-05-15 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
期权行权（卖出） |
17,744 |
- |
- |
17,744 |
| 2025-05-15 |
Sumner Michael John |
Chief Medical Officer |
期权行权（卖出） |
2,385 |
- |
- |
2,385 |
| 2025-05-10 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
期权行权（卖出） |
5,500 |
- |
- |
- |
| 2025-02-27 |
Kies Peter |
CFO |
限制性股票授予 (RSU) |
31,900 |
- |
- |
31,900 |
| 2025-02-27 |
Humeau Laurent |
Chief Scientific Officer |
限制性股票授予 (RSU) |
22,098 |
- |
- |
22,098 |
| 2025-02-27 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
限制性股票授予 (RSU) |
85,201 |
- |
- |
85,201 |
| 2025-02-27 |
Sumner Michael John |
Chief Medical Officer |
限制性股票授予 (RSU) |
34,650 |
- |
- |
34,650 |
| 2025-02-26 |
Kies Peter |
CFO |
期权行权（卖出） |
3,997 |
- |
- |
- |
| 2025-02-26 |
Weiner David B. |
Director |
期权行权（卖出） |
972 |
- |
- |
- |
| 2025-02-26 |
Humeau Laurent |
Chief Scientific Officer |
期权行权（卖出） |
3,855 |
- |
- |
- |
| 2025-02-26 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
期权行权（卖出） |
5,852 |
- |
- |
- |
| 2025-02-26 |
Sumner Michael John |
Chief Medical Officer |
期权行权（卖出） |
5,010 |
- |
- |
10,019 |
| 2024-12-18 |
Sumner Michael John |
Chief Medical Officer |
限制性股票授予 (RSU) |
4,292 |
- |
- |
4,292 |
| 2024-06-30 |
Sumner Michael John |
Chief Medical Officer |
期权行权（卖出） |
2,917 |
- |
- |
2,916 |
| 2024-05-21 |
Yarno Wendy L |
Director |
限制性股票授予 (RSU) |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Benito Simon X |
Director |
限制性股票授予 (RSU) |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Zoth Lota S. |
Director |
限制性股票授予 (RSU) |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Shepard Jay |
Director |
限制性股票授予 (RSU) |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Weiner David B. |
Director |
限制性股票授予 (RSU) |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Dansey Roger D |
Director |
限制性股票授予 (RSU) |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Miller Ann Calby |
Director |
限制性股票授予 (RSU) |
2,167 |
- |
- |
2,167 |
| 2024-05-15 |
Yarno Wendy L |
Director |
期权行权（卖出） |
2,166 |
- |
- |
- |
| 2024-05-15 |
Kies Peter |
CFO |
期权行权（卖出） |
4,771 |
- |
- |
9,542 |
| 2024-05-15 |
Benito Simon X |
Director |
期权行权（卖出） |
2,166 |
- |
- |
- |
| 2024-05-15 |
Zoth Lota S. |
Director |
期权行权（卖出） |
2,166 |
- |
- |
- |
| 2024-05-15 |
Shepard Jay |
Director |
期权行权（卖出） |
2,166 |
- |
- |
- |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
